// App-Quantinova.ai

PB0159 : Loss of function variant in SMIM1 is associated with reduced energy expenditure, weight gain and an increased risk for cardiovascular events.

Researchers

Presenter

  • L. Stefanucci

Principal Investigators

  • M. Frontini

Medical Centers

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Department of Clinical Immunology, Zealand University Hospital, Køge, Roskilde University, Denmark., Roskilde, Sjelland, Denmark

  • University of Cambridge, Cambridge, United Kingdom

  • Imperial College London, london, England, United Kingdom

  • University of Exeter, Exeter, United Kingdom

Locations

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved